Genetics Generation Advancement (ROCO:4160) Total Liabilities: NT$204.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4160 Genetics Generation Advancement Corp ROCO:4160
70 GF Score
Price NT$40.15
GF Value NT$51.36
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Genetics Generation Advancement Total Liabilities?

Genetics Generation Advancement ROCO:4160 -2.43% 70 Total Liabilities is NT$204.1 Mil as of Dec. 2025. GuruFocus rates ROCO:4160 with a GF Score™ of 70/100 and a GF Value™ of NT$51.36 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Genetics Generation Advancement's Total Liabilities for the quarter that ended in Dec. 2025 was NT$204.1 Mil.

Genetics Generation Advancement's quarterly Total Liabilities increased from Jun. 2025 (NT$185.73 Mil) to Sep. 2025 (NT$198.39 Mil) and increased from Sep. 2025 (NT$198.39 Mil) to Dec. 2025 (NT$204.05 Mil).

Genetics Generation Advancement's annual Total Liabilities increased from Dec. 2023 (NT$164.91 Mil) to Dec. 2024 (NT$170.81 Mil) and increased from Dec. 2024 (NT$170.81 Mil) to Dec. 2025 (NT$204.05 Mil).

Genetics Generation Advancement Total Liabilities Historical Data

* Premium members only.

The historical data trend for Genetics Generation Advancement's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetics Generation Advancement Total Liabilities Chart

Genetics Generation Advancement Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.06 108.20 164.91 170.81 204.05

Genetics Generation Advancement Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 170.81 166.60 185.73 198.39 204.05
ROCO:4160
70GF Score
Genetics Generation Advancement Corp ROCO:4160
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genetics Generation Advancement Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genetics Generation Advancement's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=199.331+(4.722+7.9936057773011E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=204.1

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=806.054-602.001
=204.1

Genetics Generation Advancement's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=199.331+(4.722+7.9936057773011E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=204.1

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=806.054-602.001
=204.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$204.1 Mil mean?
Genetics Generation Advancement (ROCO:4160) has a Total Liabilities of NT$204.1 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genetics Generation Advancement and its competitors.
Is Genetics Generation Advancement's Total Liabilities too high?
Genetics Generation Advancement's current Total Liabilities is NT$204.1 Mil. Overall, Genetics Generation Advancement has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genetics Generation Advancement's Total Liabilities compare to TMO and DHR?
Genetics Generation Advancement's Total Liabilities of NT$204.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genetics Generation Advancement and its competitors. Genetics Generation Advancement's current Total Liabilities is NT$204.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetics Generation Advancement stock overvalued right now?
Based on GuruFocus' analysis, Genetics Generation Advancement (ROCO:4160) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$51.36, compared to a current price of NT$40.15 — trading 21.8% below its estimated fair value. The current Total Liabilities is NT$204.1 Mil. Genetics Generation Advancement's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Genetics Generation Advancement (ROCO:4160), the current Total Liabilities is NT$204.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genetics Generation Advancement (ROCO:4160) Overvalued in 2026?

Based on GuruFocus' analysis, Genetics Generation Advancement stock appears to be undervalued. The current stock price of NT$40.15 is trading 21.8% below its estimated GF Value™ of NT$51.36. GuruFocus considers Genetics Generation Advancement to be Modestly Undervalued.

Key valuation signals for ROCO:4160:

  • Total Liabilities: NT$204.1 Mil
  • GF Value™: NT$51.36 vs. price of NT$40.15 (21.8% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genetics Generation Advancement Business Description

Address No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.
70GF Score

Get the complete analysis for ROCO:4160

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$40.15
Price
NT$51.36
GF Value